Live Pharmaceutical Import data of Russia imports from taiwan under HS Code 28 via Port Vladivostok--customs-post , our Russia customs import data reports include date, value, quantity, product description, HS code, port, country, and Russia pharmaceutical importers data
Date |
HS Code |
Product Description |
Origin Country |
Customs |
QTY. |
Unit |
Value($) |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-04-18 00:00:00 |
2836400000
|
POTASSIUM CARBONATE (POTASSIUM CARBONATE) IS NOT A PRODUCTION WASTE, NOT FOR THE PHARMACEUTICAL INDUSTRY, NOT FOR VETERINARY USE: | TAIWAN | VLADIVOSTOK CUSTOMS POST | 22500 | KG | 31500 | Importer Name |
2024-04-18 00:00:00
POTASSIUM CARBONATE (POTASSIUM CARBONATE) IS NOT A PRODUCTION WASTE, NOT FOR THE PHARMACEUTICAL INDUSTRY, NOT FOR VETERINARY USE:
22500
KG
31500
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 28 for Russia pharmaceutical imports from Thailand via Port Vladivostok--customs-post.
Port Vladivostok--customs-post typically refers to a port that is used for handling and forwarding shipments into Russia, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharmaceutical products, enabling better decision-making for trade and market expansion for Russia pharmaceutical imports from taiwan under HS code 28 via Port Vladivostok--customs-post.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharmaceutical market.
